Amorepacific Enters Medical Aesthetics Market Through HIGHER Corporation Deal

On July 30, 2026, Amorepacific Holdings signed a strategic investment agreement with HIGHER Corporation to enter the medical aesthetics market, a move that will bring a major global beauty conglomerate's research engine directly into the clinical space. For your practice, this partnership signals an upcoming pipeline of new, highly backed products designed to bridge the gap between in-office treatments and daily at-home care. The collaboration will focus on developing and commercializing skin boosters, cosmeceuticals, and post-treatment aftercare protocols, as well as medical devices such as HILO WAVE®. The two companies plan to conduct joint research on novel ingredients and materials, leveraging clinical hospital distribution networks to roll these offerings out to providers. As the line between retail skincare and professional aesthetics continues to blur, this deal suggests that we will see more sophisticated, science-driven topicals to support post-procedure healing. Clinicians should monitor these upcoming product launches as tools to enhance treatment outcomes and build out more robust, premium retail regimens for patients.

Source: MedEsthetics, https://www.medestheticsmag.com/practice-management/news/22934149/amorepacific-holdings-enters-medical-aesthetics-market-through-strategic-higher-corporation-investment